Potassium%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCl) is an essential electrolyte used to treat or prevent hypokalemia. It is available in oral and intravenous formulations. ## Primary Indications * Treatment of hypokalemia. * Prevention of hypokalemia in patients at risk (e.g., those receiving diuretics). ## Adult Dosing * **Oral:** * **Treatment of Hypokalemia:** Typically 20-60 mEq per day, divided into 2-4 doses. May require higher doses (up to 100-120 mEq/day) in severe cases. * **Prevention of Hypokalemia:** Typically 10-40 mEq per day. * Maximum single oral dose: 20 mEq to minimize gastrointestinal upset. * Maximum daily oral dose: Generally no more than 100-120 mEq/day. * **Intravenous (IV):** * **Treatment of Hypokalemia:** * For serum potassium < 3.0 mEq/L: 20 mEq per hour may be administered. * For serum potassium > 3.0 mEq/L: 10 mEq per hour is generally recommended. * Maximum IV dose: Typically 40 mEq/hour, but may be increased to 80 mEq/hour in life-threatening situations with cardiac monitoring. **Higher infusion rates may be associated with increased risk of cardiac arrhythmias and cardiac arrest.** * **Dilution:** IV potassium chloride must be diluted. Peripheral IV administration should generally not exceed 40 mEq/L. Central venous access allows for higher concentrations (up to 80-100 mEq/L), but this is dependent on local protocols and extreme caution. ## Pediatric Dosing * **Oral:** * Recommended daily allowance (RDA) varies by age, but typical maintenance doses range from 1-5 mEq/kg/day. * Treatment of hypokalemia: May require higher doses, often guided by serum potassium levels and clinical response. Dosing should be individualized. * **Intravenous (IV):** * Dosing should be individualized based on serum potassium levels, age, and clinical status. * Typical infusion rates are 0.3-0.5 mEq/kg/hour. * Maximum infusion rate: Generally 1 mEq/kg/hour, but may be increased to 2 mEq/kg/hour in critical situations with continuous cardiac monitoring and close electrolyte monitoring. **Rapid IV infusion can be fatal.** * Maximum concentration for peripheral IV administration: 40 mEq/L. Higher concentrations may be used with central venous access, as per local policy. ## Dose Adjustments * **Renal Impairment:** Use with extreme caution. Reduce dose and monitor potassium levels closely. Severe renal impairment may preclude use or require very cautious, low-dose administration. * **Adrenal Insufficiency:** Increased risk of hyperkalemia. ## Contraindications * Hyperkalemia (serum potassium > 5.0 mEq/L). * Conditions leading to elevated potassium levels, such as untreated Addison's disease, severe renal impairment, or simultaneous use of potassium-sparing diuretics (unless carefully monitored). * Certain gastrointestinal conditions (e.g., esophageal compression, delayed gastric emptying) may preclude the use of solid oral dosage forms. ## Adverse Effects * **Common:** Gastrointestinal upset (nausea, vomiting, diarrhea, abdominal pain), especially with oral administration. * **Serious:** Hyperkalemia (can be life-threatening with symptoms including muscle weakness, fatigue, paresthesias, cardiac arrhythmias, bradycardia, hypotension, and cardiac arrest), esophageal or gastric ulceration/perforation (with oral forms, especially if not taken with sufficient fluid or in patients with motility issues). ## Key Drug Interactions * **Potassium-Sparing Diuretics (e.g., spironolactone, amiloride, triamterene), ACE inhibitors, Angiotensin Receptor Blockers (ARBs), NSAIDs, Heparin, Trimethoprim:** Increase the risk of hyperkalemia. * **Corticosteroids:** May increase potassium loss, potentially counteracting the effects of potassium supplementation. ## Monitoring * **Serum Potassium:** Essential, especially during IV administration, with dose adjustments, in patients with renal impairment, and when initiating or discontinuing interacting medications. * **Renal Function:** Monitor serum creatinine and BUN. * **ECG:** Especially with rapid IV administration or suspicion of hyperkalemia. * **Signs and symptoms of hypokalemia and hyperkalemia.** ## Clinical Pearls * Oral potassium chloride should be taken with meals and a full glass of water to minimize gastrointestinal irritation. * Liquid formulations may be preferred in patients with difficulty swallowing or a history of gastrointestinal issues. * Intravenous administration requires careful attention to infusion rate, concentration, and patient monitoring due to the risk of severe adverse events, including cardiac arrest. * Always confirm the correct concentration and infusion rate with pharmacy or institutional policy before administering IV potassium. * Dosing should be guided by serum potassium levels and clinical assessment. *** *Disclaimer: This information is intended for healthcare professionals. Always consult the official prescribing information and current clinical guidelines for the most up-to-date and complete drug information.*